|
|||||
|
|
Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised,double‐blind,placebo‐controlled EIGHT trial |
|
| Authors: | Christopher Chapple Tim Schneider François Haab Franklin Sun Laurence Whelan David Scholfield Erika Dragon Erin Mangan |
| Affiliation: | 1. The Royal Hallamshire Hospital, , Sheffield, UK;2. Praxisklinik Urologie Rhein/Ruhr, , Mülheim, Germany;3. H?pital Tenon, , Paris, France;4. Pfizer Inc., , New York, NY, USA;5. Pfizer Ltd, , Walton Oaks, UK;6. Pfizer PIO, , Paris, France |
| Abstract: | |
| Keywords: | fesoterodine dose comparison urgency urinary incontinence overactive bladder dose response dose titration |